XPARLBIRD
Market cap207mUSD
Dec 24, Last price
9.08EUR
1D
0.89%
1Q
13.50%
Jan 2017
181.69%
Name
Lumibird SA
Chart & Performance
Profile
Lumibird SA designs, manufactures, and sells various lasers for the scientific, industrial, and medical applications worldwide. It operates in two divisions, Photonics and Medical. The Photonics division offers solid-state lasers, high power laser diodes, fiber lasers, fiber amplifiers and components, photonics solutions for time-of-flight lidar and range-finding, and doppler lidar systems for wind measurement. Its products are used in various applications, such as industrial and scientific, defense and space, and lidar sensors. The Medical division provides medical and ophthalmological solutions from diagnosis to laser treatment. The company was founded in 1970 and is headquartered in Lannion, France.
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 206,554 8.17% | 190,959 17.54% | 162,468 28.20% | |||||||
Cost of revenue | 90,469 | 192,699 | 179,531 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 116,085 | (1,740) | (17,063) | |||||||
NOPBT Margin | 56.20% | |||||||||
Operating Taxes | 327 | 3,084 | 3,745 | |||||||
Tax Rate | 0.28% | |||||||||
NOPAT | 115,758 | (4,824) | (20,808) | |||||||
Net income | 7,126 -37.23% | 11,353 -18.08% | 13,858 145.80% | |||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | (3,161) | (1,407) | 207 | |||||||
BB yield | 1.17% | 0.38% | -0.04% | |||||||
Debt | ||||||||||
Debt current | 16,475 | 65,562 | 14,172 | |||||||
Long-term debt | 138,431 | 48,618 | 97,860 | |||||||
Deferred revenue | 596 | 688 | 1,216 | |||||||
Other long-term liabilities | 2,831 | 10,317 | 9,380 | |||||||
Net debt | 87,712 | 41,547 | 4,549 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 20,667 | 1,427 | 26,575 | |||||||
CAPEX | (25,554) | (29,445) | (20,106) | |||||||
Cash from investing activities | (46,151) | (29,337) | (28,633) | |||||||
Cash from financing activities | 21,690 | (7,890) | 18,205 | |||||||
FCF | 155,402 | (36,125) | (21,905) | |||||||
Balance | ||||||||||
Cash | 56,195 | 61,677 | 97,128 | |||||||
Long term investments | 10,999 | 10,956 | 10,355 | |||||||
Excess cash | 56,866 | 63,085 | 99,360 | |||||||
Stockholders' equity | 113,939 | 122,291 | 111,677 | |||||||
Invested Capital | 288,905 | 251,241 | 202,744 | |||||||
ROIC | 42.86% | |||||||||
ROCE | 33.39% | |||||||||
EV | ||||||||||
Common stock shares outstanding | 22,275 | 22,450 | 22,444 | |||||||
Price | 12.18 -26.45% | 16.56 -31.14% | 24.05 71.30% | |||||||
Market cap | 271,306 -27.02% | 371,771 -31.13% | 539,780 73.19% | |||||||
EV | 359,018 | 413,318 | 544,329 | |||||||
EBITDA | 131,755 | 12,565 | (5,030) | |||||||
EV/EBITDA | 2.72 | 32.89 | ||||||||
Interest | 4,187 | 3,344 | 2,261 | |||||||
Interest/NOPBT | 3.61% |